Evolving Treatment Landscape Of nmCRPC

Evolving Treatment Landscape Of nmCRPC

obr

1 year
59 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Nicholas Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, Discusses Combining Checkpoint Inhibitors In mCRPC. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019.

http://obroncology.com
Up Next Autoplay